Reiman, T., Savage, K. J., Crump, M., Cheung, M. C., MacDonald, D., Buckstein, R., Couban, S., Piliotis, E., Imrie, K., Spaner, D., Shivakumar, S., Kuruvilla, J., Villa, D., Shepherd, L. E., Skamene, T., Winch, C., Chen, B. E., & Hay, A. E. (2019). A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Leukemia and Lymphoma, 60(4), 912-919. https://doi.org/10.1080/10428194.2018.1515937
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. / Reiman, Tony; Savage, Kerry J.; Crump, Michael et al.
In:
Leukemia and Lymphoma, Vol. 60, No. 4, 21.03.2019, p. 912-919.
Research output: Contribution to journal › Article › peer-review
Reiman, T, Savage, KJ, Crump, M, Cheung, MC, MacDonald, D, Buckstein, R, Couban, S, Piliotis, E, Imrie, K, Spaner, D, Shivakumar, S, Kuruvilla, J, Villa, D, Shepherd, LE, Skamene, T, Winch, C, Chen, BE & Hay, AE 2019, 'A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†', Leukemia and Lymphoma, vol. 60, no. 4, pp. 912-919. https://doi.org/10.1080/10428194.2018.1515937
Reiman T, Savage KJ, Crump M, Cheung MC, MacDonald D, Buckstein R et al. A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Leukemia and Lymphoma. 2019 Mar 21;60(4):912-919. doi: 10.1080/10428194.2018.1515937
Reiman, Tony ; Savage, Kerry J. ; Crump, Michael et al. / A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. In: Leukemia and Lymphoma. 2019 ; Vol. 60, No. 4. pp. 912-919.
@article{53441e54501b44a39c78d4b305b3db2c,
title = "A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†",
keywords = "Non-Hodgkin lymphoma, combination therapy, phase I trial, romidepsin",
author = "Tony Reiman and Savage, {Kerry J.} and Michael Crump and Cheung, {Matthew C.} and David MacDonald and Rena Buckstein and Stephen Couban and Eugenia Piliotis and Kevin Imrie and David Spaner and Sudeep Shivakumar and John Kuruvilla and Diego Villa and Shepherd, {Lois E.} and Tanya Skamene and Chad Winch and Chen, {Bingshu E.} and Hay, {Annette E.}",
note = "Publisher Copyright: {\textcopyright} 2018, {\textcopyright} 2018 Informa UK Limited, trading as Taylor & Francis Group.",
year = "2019",
month = mar,
day = "21",
doi = "10.1080/10428194.2018.1515937",
language = "English",
volume = "60",
pages = "912--919",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "4",
}
TY - JOUR
T1 - A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
AU - Reiman, Tony
AU - Savage, Kerry J.
AU - Crump, Michael
AU - Cheung, Matthew C.
AU - MacDonald, David
AU - Buckstein, Rena
AU - Couban, Stephen
AU - Piliotis, Eugenia
AU - Imrie, Kevin
AU - Spaner, David
AU - Shivakumar, Sudeep
AU - Kuruvilla, John
AU - Villa, Diego
AU - Shepherd, Lois E.
AU - Skamene, Tanya
AU - Winch, Chad
AU - Chen, Bingshu E.
AU - Hay, Annette E.
N1 - Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/3/21
Y1 - 2019/3/21
KW - Non-Hodgkin lymphoma
KW - combination therapy
KW - phase I trial
KW - romidepsin
UR - http://www.scopus.com/inward/record.url?scp=85054680037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054680037&partnerID=8YFLogxK
U2 - 10.1080/10428194.2018.1515937
DO - 10.1080/10428194.2018.1515937
M3 - Article
C2 - 30301414
AN - SCOPUS:85054680037
SN - 1042-8194
VL - 60
SP - 912
EP - 919
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 4
ER -
